Association of sunbed use with skin cancer risk factors in Europe: an investigation within the Euromelanoma skin cancer prevention campaign

Journal of the European Academy of Dermatology and Venereology : JEADV
M SuppaV Del Marmol

Abstract

Sunbed use has been significantly associated with increased risk of melanoma and non-melanoma skin cancer (NMSC), but its relationship with melanoma's risk factors such as high nevus count, atypical nevi and lentigines is poorly studied. Euromelanoma is a skin cancer prevention campaign conducted all over Europe. It offers a once-a-year screening during which participants' data, including sunbed use and phenotype, are collected via questionnaires. To investigate the association of sunbed use with nevus count, atypical nevi, lentigines and suspicion of skin cancer. To ensure reliability of the data, we defined inclusion and exclusion criteria for countries' eligibility for the risk analysis. Multivariate logistic regression models (including age, gender, education, skin type, family history of melanoma, personal history of skin cancer, any sun exposure and any sunscreen use) were used to calculate summary odds ratios (SORs) of each clinical endpoint for ever sunbed use. Overall, 227 888 individuals from 30 countries completed the Euromelanoma questionnaire. After the data quality check, 16 countries were eligible for the multivariate analysis, for a total of 145 980 participants (64.8% females; median age 43 years; 62.3% highly ...Continue Reading

References

Nov 1, 1990·Journal of the American Academy of Dermatology·D P KadunceJ J Zone
May 1, 1989·Journal of the American Academy of Dermatology·D E RothJ P Callen
Oct 1, 1989·Journal of the American Academy of Dermatology·J R SalisburyA W du Vivier
Apr 16, 1988·British Medical Journal·H C WilliamsA du Vivier
Jul 1, 1987·The British Journal of Dermatology·S K JonesR M Mackie
Oct 1, 1980·Archives of Dermatology·W MontagnaK Carlisle
Feb 15, 1994·American Journal of Epidemiology·D R English, B K Armstrong
May 1, 1994·The British Journal of Dermatology·L FritschiV Siskind
Jan 1, 1994·Journal of the American Academy of Dermatology·J W KellyB J Tate
Jan 29, 1999·Archives of Dermatology·S L HarrisonR MacLennan
Feb 24, 2001·Acta Dermato-venereologica·P KarlssonI Rosdahl
Apr 23, 2002·The British Journal of Dermatology·Thomas L Diepgen, V Mahler
May 11, 2002·Journal of the American Academy of Dermatology·Steven DarlingtonAdele Green
Jul 12, 2002·Statistics in Medicine·Julian P T Higgins, Simon G Thompson
Jan 1, 2003·Journal of Clinical Epidemiology·Madeleine DulonEckard W Breitbart
Mar 15, 2003·Journal of the American Academy of Dermatology·Robert MacLennanSimone L Harrison
Aug 15, 2003·International Journal of Cancer. Journal International Du Cancer·David C WhitemanMaria-Celia Hughes
Aug 30, 2003·Cancer Causes & Control : CCC·Philippe AutierUNKNOWN European Organisation for Research and Treatment of Cancer Melanoma Group
Jun 23, 2004·Acta Dermato-venereologica·Yolanda Hidalgo GarcíaNarciso Pérez Oĺiva
Dec 25, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sara GandiniCarmelo Francesco Melchi
Jan 13, 2005·International Journal of Cancer. Journal International Du Cancer·Jürgen BauerClaus Garbe
Mar 16, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Richard P GallagherTim K Lee
Jan 18, 2006·Cancer Causes & Control : CCC·Dallas R EnglishJulie A Simpson
Mar 20, 2008·Advances in Experimental Medicine and Biology·Ulrike Leiter, Claus Garbe
Dec 20, 2008·Clinics in Dermatology·Robert J FriedmanEdward R Heilman
Feb 5, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Kelly J PettijohnLori A Crane
Aug 6, 2009·The Lancet Oncology·Fatiha El GhissassiUNKNOWN WHO International Agency for Research on Cancer Monograph Working Group
Sep 23, 2009·Archives of Dermatology·Jenny AalborgLori A Crane
Jan 9, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Marit Bragelien VeierødElisabete Weiderpass
Sep 13, 2011·Progress in Biophysics and Molecular Biology·Adèle C GreenPenelope McBride
Sep 29, 2011·Journal of the European Academy of Dermatology and Venereology : JEADV·R J T van der LeestV del Marmol
Jul 27, 2012·BMJ : British Medical Journal·Mathieu BoniolSara Gandini
Oct 4, 2012·BMJ : British Medical Journal·Mackenzie R WehnerEleni Linos
Dec 13, 2012·International Journal of Dermatology·Mariano SuppaUNKNOWN Italian investigators for the Euromelanoma prevention campaign
Jan 26, 2013·Journal of the European Academy of Dermatology and Venereology : JEADV·I SchaeferT Kornek
Apr 4, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Alisa M Goldstein, Margaret A Tucker
Jan 31, 2014·JAMA Dermatology·Mackenzie R WehnerEleni Linos
Mar 19, 2014·Journal of the American Academy of Dermatology·Sophia ColantonioJennifer Beecker
Jun 28, 2014·Biochemia Medica·Matthew S Thiese
Jun 23, 2015·Annals of Epidemiology·Jaya M SatagopanAllan C Halpern
Oct 20, 2015·Photodermatology, Photoimmunology & Photomedicine·Emese GellénÉva Remenyik

❮ Previous
Next ❯

Citations

Jan 25, 2019·Current Opinion in Oncology·Mariano Suppa, Sara Gandini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the American Academy of Dermatology
Reid A Waldman, Jane M Grant-Kels
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
S A OliveriaM Berwick
Journal of the European Academy of Dermatology and Venereology : JEADV
E NagoreC Guillen
© 2022 Meta ULC. All rights reserved